Advertisement

Sleep Medicine pp 167-179 | Cite as

Sleep and HIV Disease

  • Kenneth D. PhillipsEmail author
  • Mary E. Gunther
Chapter

Abstract

Although not the fatal illness it once was, HIV/AIDS remains a life-threatening illness. The worldwide prevalence of HIV/AIDS at the end of 2010 was estimated to be 34 million, which includes 3.4 million children who are less than 15 years of age. The incidence of HIV infection decreased from 3.1 million in 2001 to 2.7 million in 2010. The annual number of deaths worldwide is steadily declining since peaking in 2005 at 2.2 million.

Keywords

HIV AIDS Sleep medicine Insomnia in AIDS Sleep architecture in AIDS 

References

  1. 1.
    WHO. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Geneva: World Health Organization; 2011.Google Scholar
  2. 2.
    Gamaldo CE, Spira AP, Hock RS, et al. Sleep, function and HIV: a multi-method assessment. AIDS Behav. 2013; 17(8):2808–15;17(8):2808–15.Google Scholar
  3. 3.
    Robbins JL, Phillips KD, Dudgeon WD, H and GA. Physiological and psychological correlates of sleep in HIV infection. Clin Nurs Res. 2004;13(1):33–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Hudson A, Kirksey K, Holzemer W. The influence of symptoms on quality of life among HIV-infected women. West J Nurs Res. 2004;26(1):9–23.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee KA, Gay C, Portillo CJ, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Symptom Manage. 2009;38(6):882–93.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Rubinstein ML, Selwyn PA. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):260–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Keenan S, Hirchowitz M. Monitoring and staging human sleep. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 5th ed. St Louis: Elsevier-Saunders; 2011. pp. 1602–9.Google Scholar
  8. 8.
    Darko DF, McCutchan JA, Kripke DF, Gillin JC, Golshan S. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry. 1992;149(4):514–20.PubMedCrossRefGoogle Scholar
  9. 9.
    Reid S, Dwyer J. Insomnia in HIV infection: a systematic review of prevalence, correlates, and management. Psychosom Med. 2005;67(2):260–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011;25(9):517–24.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Norman SE, Resnick L, Cohn MA, Duara R, Herbst J, Berger JR. Sleep disturbances in HIV-seropositive patients. JAMA. 1988;260(7):922.PubMedCrossRefGoogle Scholar
  12. 12.
    Crum-Cianflone NF, Roediger MP, Moore DJ, et al. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012;54(10):1485–94.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Norman SE, Chediak AD, Freeman C, et al. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep. 1992;15(2):150–5.PubMedGoogle Scholar
  14. 14.
    Wiegand M, Moller AA, Schreiber W, Krieg JC, Holsboer F. Alterations of nocturnal sleep in patients with HIV infection. Acta Neurol Scand. 1991;83(2):141–2.PubMedCrossRefGoogle Scholar
  15. 15.
    Terstegge K, Henkes H, Scheuler W, Hansen ML, Ruf B, Kubicki S. Spectral power and coherence analysis of sleep EEG in AIDS patients: decrease in interhemispheric coherence. Sleep 1993;16(2):137–45.PubMedGoogle Scholar
  16. 16.
    Kubicki S, Henkes H, Terstegge K, Ruf B. AIDS related sleep disturbances: a preliminary report. HIV and nervous system. New York: Fischer; 1988. pp. 97–105.Google Scholar
  17. 17.
    Nokes KM, Kendrew J. Correlates of sleep quality in persons with HIV disease. J Assoc Nurses AIDS Care. 2001;12(1):17–22.PubMedCrossRefGoogle Scholar
  18. 18.
    Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr. 1999;21(2):126–33.PubMedGoogle Scholar
  19. 19.
    Hudson AL, Portillo CJ, Lee KA. Sleep disturbances in women with HIV or AIDS: efficacy of a tailored sleep promotion intervention. Nurs Res. 2008;57(5):360–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Lee KA, Portillo CJ, Miramontes H. The influence of sleep and activity patterns on fatigue in women with HIV/AIDS. J Assoc Nurses AIDS Care 2001;12(Suppl):19–27.PubMedCrossRefGoogle Scholar
  21. 21.
    Vogl D, Rosenfeld B, Breitbart W, et al. Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage. 1999;18(4):253–62.PubMedCrossRefGoogle Scholar
  22. 22.
    Bayon C, Ribera E, Cabrero E, Griffa L, Burgos A. Prevalence of depressive and other central nervous system symptoms in HIV-infected patients treated with HAART in Spain. J Int Assoc Physicians AIDS Care (Chic) 2012;11(5):321–8.CrossRefGoogle Scholar
  23. 23.
    Ohayon MM, Sagales T. Prevalence of insomnia and sleep characteristics in the general population of Spain. Sleep Med. 2010;11(10):1010–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Lee KA, Gay C, Portillo CJ, et al. Types of sleep problems in adults living with HIV/AIDS. J Clin Sleep Med. 2012;8(1):67–75.PubMedCentralPubMedGoogle Scholar
  25. 25.
    Moeller AA, Oechsner M, Backmund HC, Popescu M, Emminger C, Holsboer F. Self-reported sleep quality in HIV infection: correlation to the stage of infection and zidovudine therapy. J Acquir Immune Defic Syndr. 1991;4(10):1000–3.PubMedGoogle Scholar
  26. 26.
    Phillips KD, Sowell RL, Rojas M, Tavakoli A, Fulk LJ, H and GA. Physiological and psychological correlates of fatigue in HIV disease. Biol Res Nurs. 2004;6(1):59–74.PubMedCrossRefGoogle Scholar
  27. 27.
    Phillips KD, Sowell RL, Boyd M, Dudgeon WD, Hand GA. Sleep quality and health-related quality of life in HIV-infected African-American women of childbearing age. Qual Life Res. 2005;14(4):959–70.PubMedCrossRefGoogle Scholar
  28. 28.
    Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch. 2012;463(1):121–37.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Darko DF, Mitler MM, Henriksen SJ. Lentiviral infection, immune response peptides and sleep. Adv Neuroimmunol. 1995;5(1):57–77.PubMedCrossRefGoogle Scholar
  30. 30.
    Cruess DG, Antoni MH, Gonzalez J, et al. Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. J Psychosom Res. 2003;54(3):185–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Norman SE, Chediak AD, Kiel M, Cohn MA. Sleep disturbances in HIV-infected homosexual men. AIDS. 1990;4(8):775–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Norman SE, Shaukat M, Nay KN, Cohn M, Resnick L. Alterations in sleep architecture in asymptomatic HIV seropositive patients. Sleep Res. 1987;16:494.Google Scholar
  33. 33.
    Norman SE, Kiel M, Nay KN, Demirozu MC, Dunbar S, Cohn MA. Alpha-delta sleep pattern and circadian rhythmicity in HIV seropositive patients. Sleep Res. 1989;17:353.Google Scholar
  34. 34.
    Kubicki S, Henkes H, Terstegge K, Ruf B. AIDS related sleep disturbances: a preliminary report. In: Kubicki S, Henkes H, Bienzle U, Pohle HD, editors. HIV and the nervous system. New York: Gustav Fischer; 1988. pp. 97–105.Google Scholar
  35. 35.
    Wiegand M, Moller AA, Schreiber W, et al. Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatry Clin Neurosci. 1991;240(3):153–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Ferini-Strambi L, Oldani A, Tirloni G, et al. Slow wave sleep and cyclic alternating pattern (CAP) in HIV-infected asymptomatic men. Sleep. 1995;18(6):446–50.PubMedGoogle Scholar
  37. 37.
    Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV –1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRefGoogle Scholar
  38. 38.
    Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33(8):1417–23.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Bangsberg DR. Less than 95 % adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939–41.PubMedCrossRefGoogle Scholar
  40. 40.
    Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194–200.PubMedCrossRefGoogle Scholar
  41. 41.
    Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.PubMedCrossRefGoogle Scholar
  42. 42.
    CDC. Effect of antiretroviral therapy on risk of sexual transmission of HIV infection and superinfection. Centers for Disease Control and Prevention; 2009. http://www.cdc.gov/hiv/topics/treatment/resources/factsheets/pdf/art.pdf. Accessed 1 Feb 2013.
  43. 43.
    Gay C, Portillo CJ, Kelly R, et al. Self-reported medication adherence and symptom experience in adults with HIV. J Assoc Nurses AIDS Care. 2011;22(4):257–68.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Phillips KD, Moneyham L, Murdaugh C, et al. Sleep disturbance and depression as barriers to adherence. Clin Nurs Res. 2005;14(3):273–93.PubMedCrossRefGoogle Scholar
  45. 45.
    Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28(5):445–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Pedrol E, Tasias M, Clotet B, et al. Study to determine the improvement in neuropsychiatric symptoms after changing the responsible antiretroviral drug to nevirapine: the RELAX study. J Int AIDS Soc. 2012;15(6):18347.Google Scholar
  47. 47.
    Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(Suppl 2):S354–8.Google Scholar
  48. 48.
    Ustinov Y, Lichstein KL, Wal GS, Taylor DJ, Riedel BW, Bush AJ. Association between report of insomnia and daytime functioning. Sleep Med. 2010;11(1):65–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Aouizerat BE, Gay CL, Lerdal A, Portillo CJ, Lee KA. Lack of energy: an important and distinct component of HIV-related fatigue and daytime function. J. Pain Symptom Manage. 2013;45(2):191–201.Google Scholar
  50. 50.
    Aouizerat BE, Miaskowski CA, Gay C, et al. Risk factors and symptoms associated with pain in HIV-infected adults. J Assoc Nurses AIDS Care. 2010;21(2):125–33.PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Taibi DM. Sleep disturbances in persons living with HIV. J Assoc Nurses AIDS Care. 2013;24(Suppl 1):S72–85.CrossRefGoogle Scholar
  52. 52.
    Barroso J, Voss JG. Fatigue in HIV and AIDS: an analysis of evidence. J Assoc Nurses AIDS Care. 2013;24(Suppl 1):S5–14.CrossRefGoogle Scholar
  53. 53.
    Lerdal A, Gay CL, Aouizerat BE, Portillo CJ, Lee KA. Patterns of morning and evening fatigue among adults with HIV/AIDS. J Clin Nurs. 2011;20(15–16):2204–16.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Siegel K, Bradley CJ, Lekas HM. Causal attributions for fatigue among late middle-aged and older adults with HIV infection. J Pain Symptom Manage. 2004;28(3):211–24.PubMedCrossRefGoogle Scholar
  55. 55.
    Voss JG, Dodd M, Portillo C, Holzemer W. Theories of fatigue: application in HIV/AIDS. J Assoc Nurses AIDS Care. 2006;17(1):37–50.PubMedCrossRefGoogle Scholar
  56. 56.
    Darko DF, Mitler MM, Miller JC. Growth hormone, fatigue, poor sleep, and disability in HIV infection. Neuroendocrinology. 1998;67(5):317–24.PubMedCrossRefGoogle Scholar
  57. 57.
    Harmon JL, Barroso J, Pence BW, Leserman J, Salahuddin N. Demographic and illness-related variables associated with HIV-related fatigue. J Assoc Nurses AIDS Care. 2008;19(2):90–7.PubMedCentralPubMedCrossRefGoogle Scholar
  58. 58.
    Salahuddin N, Barroso J, Leserman J, Harmon JL, Pence BW. Daytime sleepiness, nighttime sleep quality, stressful life events, and HIV-related fatigue. J Assoc Nurses AIDS Care. 2009;20(1):6–13.PubMedCentralPubMedCrossRefGoogle Scholar
  59. 59.
    Moneyham L, Murdaugh C, Phillips K, et al. Patterns of risk of depressive symptoms among HIV-positive women in the southeastern United States. J Assoc Nurses AIDS Care. 2005;16(4):25–38.PubMedCrossRefGoogle Scholar
  60. 60.
    Low Y, Preud'homme X, Goforth HW, Omonuwa T, Krystal AD. The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study. Sleep. 2011;34(12):1723–6.PubMedCentralPubMedGoogle Scholar
  61. 61.
    Kemppainen JK, Mackain S, Reyes D. Anxiety symptoms in HIV-infected individuals. J Assoc Nurses AIDS Care. 2013;24(Suppl 1):S29–39.CrossRefGoogle Scholar
  62. 62.
    Kowal J, Overduin LY, Balfour L, Tasca GA, Corace K, Cameron DW. The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. J Pain Symptom Manage. 2008;36(3):247–58.PubMedCrossRefGoogle Scholar
  63. 63.
    National Institutes of Health. NIH releases statement on behavioral and relaxation approaches for chronic pain and insomnia. Am Fam Physician. 1996;53:1877–80.Google Scholar
  64. 64.
    National Institutes of Health. Consensus development conference statement: the treatment of sleep disorders of older people. Sleep. 1991;14:169–77.Google Scholar
  65. 65.
    NIH. State of the science conference statement on manifestations and management of chronic Insomnia in adults. NIH Consens Sci Statments. 2005;22(2):1–39.Google Scholar
  66. 66.
    Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5–11.PubMedCrossRefGoogle Scholar
  67. 67.
    Morin CM, Benca R. Chronic insomnia. Lancet. 2012;379(9821):1129–41.PubMedCrossRefGoogle Scholar
  68. 68.
    Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63(1):79–89.PubMedCrossRefGoogle Scholar
  69. 69.
    Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151(8):1172–80.PubMedCrossRefGoogle Scholar
  70. 70.
    Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia. Sleep. 1999;22(8):1134–56.PubMedGoogle Scholar
  71. 71.
    Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55 + years of age. Health Psychol. 2006;25(1):3–14.PubMedCrossRefGoogle Scholar
  72. 72.
    McCurry SM, Logsdon RG, Teri L, Vitiello MV. Evidence-based psychological treatments for insomnia in older adults. Psychol Aging. 2007;22(1):18–27.PubMedCrossRefGoogle Scholar
  73. 73.
    Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004). Sleep. 2006;29(11):1398–414.PubMedGoogle Scholar
  74. 74.
    Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. Sleep. 2006;29(11):1415–9.PubMedGoogle Scholar
  75. 75.
    Reinecke MA. Cognitive therapies of depression: a modularized treatment approach. In: Reinecke MA, Davison MR, editors. Comparative treatments of depression. New York: Springer; 2002. pp. 249–90.Google Scholar
  76. 76.
    Beck AT. Cognitive therapies and emotional disorders. New York: New American Library; 1976.Google Scholar
  77. 77.
    Hofmann SG. An introduction to modern CBT: pyshcological solutions to mental health problems. Chichester, West Sussex, U.K.: Wiley-Blackwell; 2011.Google Scholar
  78. 78.
    Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285(14):1856–64.PubMedCrossRefGoogle Scholar
  79. 79.
    Mimeault V, Morin CM. Self-help treatment for insomnia: bibliotherapy with and without professional guidance. J Consult Clin Psychol. 1999;67(4):511–9.PubMedCrossRefGoogle Scholar
  80. 80.
    Morin CM, Kowatch RA, Barry T, Walton E. Cognitive-behavior therapy for late-life insomnia. J Consult Clin Psychol. 1993;61(1):137–46.PubMedCrossRefGoogle Scholar
  81. 81.
    Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281(11):991–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Savard J, Davidson JR, Ivers H, et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage. 2004;27(6):513–22.PubMedCrossRefGoogle Scholar
  83. 83.
    Perlis ML, Smith MT, Orff H, et al. The effects of modafinil and cognitive behavior therapy on sleep continuity in patients with primary insomnia. Sleep. 2004;27(4):715–25.PubMedGoogle Scholar
  84. 84.
    Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164(17):1888–96.PubMedCrossRefGoogle Scholar
  85. 85.
    Quesnel C, Savard J, Simard S, Ivers H, Morin CM. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol. 2003;71(1):189–200.PubMedCrossRefGoogle Scholar
  86. 86.
    Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol. 2005;23(25):6083–96.PubMedCrossRefGoogle Scholar
  87. 87.
    Homsey M, O’Connell K. Use and success of pharmacologic and nonpharmacologic strategies for sleep problems. J Am Acad Nurse Pract. 2012;24(10):612–23.PubMedCrossRefGoogle Scholar
  88. 88.
    Hauri P. Current concepts: the sleep disorders. Kalamazoo: The Upjohn; 1977.Google Scholar
  89. 89.
    Gigli GL, Valente M. Should the definition of “sleep hygiene” be antedated of a century? a historical note based on an old book by Paolo Mantegazza, rediscovered: to place in a new historical context the development of the concept of sleep hygiene. Neurol Sci. 2013;26(2):85–91.Google Scholar
  90. 90.
    American Academy of Sleep Medicine. Sleep hygiene: behaviors that promote sound sleep. Westchester: American Academy of Sleep Medicine; 2002.Google Scholar
  91. 91.
    AASM. Sleep hygiene: the health habits of good sleep. 2010. http://yoursleep.aasmnet.org/Hygiene.aspx. Accessed: 18 Jan 2013.
  92. 92.
    Dreher HM. The effect of caffeine reduction on sleep quality and well-being in persons with HIV. J Psychosom Res. 2003;54(3):191–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Webel AR, Moore SM, Hanson JE, Patel SR, Schmotzer B, Salata RA. Improving sleep hygiene behavior in adults living with HIV/AIDS: a randomized control pilot study of the system CHANGE™-HIV intervention. Appl Nurs Res 2013;26(2):85–91.Google Scholar
  94. 94.
    Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 2003;7(3):215–25.PubMedCrossRefGoogle Scholar
  95. 95.
    Jacobson E. Progressive relaxation. Chicago: University of Chicago Press; 1938.Google Scholar
  96. 96.
    Means MK, Lichstein KL, Epperson MT, Johnson CT. Relaxation therapy for insomnia: nighttime and day time effects. Behav Res Ther. 2000;38(7):665–78.PubMedCrossRefGoogle Scholar
  97. 97.
    Schultz J, Luthe W. Autogenic training a psychophysiologic approach in psychotherapy. New York: Grune and Stratton; 1969.Google Scholar
  98. 98.
    Bowden A, Lorenc A, Robinson N. Autogenic training as a behavioural approach to insomnia: a prospective cohort study. Prim Health Care Res Dev. 2012;13(2):175–85.PubMedCrossRefGoogle Scholar
  99. 99.
    Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedCentralPubMedGoogle Scholar
  100. 100.
    Benson H. The relaxation response. New York: Morrow; 1975.Google Scholar
  101. 101.
    Riedel B, Lichstein K, Peterson BA, Epperson MT, Means MK, Aguillard RN. A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs. Behav Modif. 1998;22(1):3–28.PubMedCrossRefGoogle Scholar
  102. 102.
    Espie CA, Lindsay WR, Brooks DN, Hood EM, Turvey T. A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther. 1989;27(1):79–88.PubMedCrossRefGoogle Scholar
  103. 103.
    Lacks P, Bertelson AD, Sugerman J, Kunkel J. The treatment of sleep-maintenance insomnia with stimulus-control techniques. Behav Res Ther. 1983;21(3):291–5.PubMedCrossRefGoogle Scholar
  104. 104.
    Morin CM, Azrin NH. Behavioral and cognitive treatments of geriatric insomnia. J Consult Clin Psychol. 1988;56(5):748–53.PubMedCrossRefGoogle Scholar
  105. 105.
    Morin CM, Azrin NH. Stimulus control and imagery training in treating sleep-maintenance insomnia. J Consult Clin Psychol. 1987;55(2):260–2.PubMedCrossRefGoogle Scholar
  106. 106.
    Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987;10(1):45–56.PubMedGoogle Scholar
  107. 107.
    Friedman L, Bliwise DL, Yesavage JA, Salom SR. A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. J Gerontol. 1991;46(1):1–8.CrossRefGoogle Scholar
  108. 108.
    Rubinstein ML, Rothenberg SA, Maheswaran S, Tsai JS, Zozula R, Spielman AJ. Modified sleep restriction therapy in middle-aged and elderly chronic insomniacs. Sleep Res. 1990;19:276.Google Scholar
  109. 109.
    Vande Griend JP, Anderson SL. Histamine − 1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc. (2003) 2012;52(6):e210–9.CrossRefGoogle Scholar
  110. 110.
    Santana CA, Fernandez F. Sleep disorders. In: Fernandez F, Ruiz P, editors. Psychiatric aspects of HIV/AIDS. Philadelphia: Lippincott Williams & Wilkins; 2006:137–46.Google Scholar
  111. 111.
    Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res. 1993;14(1):1–10.PubMedCrossRefGoogle Scholar
  112. 112.
    Lemoine P, Zisapel N. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opin Pharmacother. 2012;13(6):895–905.PubMedCrossRefGoogle Scholar
  113. 113.
    Nunnari G, Nigro L, Palermo F, Leto D, Pomerantz RJ, Cacopardo B. Reduction of serum melatonin levels in HIV − 1-infected individuals’ parallel disease progression: correlation with serum interleukin − 12 levels. Infection 2003;31(6):379–82.PubMedGoogle Scholar
  114. 114.
    Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76(3):391–6.PubMedGoogle Scholar
  115. 115.
    Roth T, Rogowski R, Hull S, et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep. 2007;30(11):1555–61.PubMedCentralPubMedGoogle Scholar
  116. 116.
    Scharf M, Rogowski R, Hull S, et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry. 2008;69(10):1557–64.PubMedCrossRefGoogle Scholar
  117. 117.
    Krystal AD, Durrence HH, Scharf M, et al.: Efficacy and safety of Doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary Insomnia. Sleep. 2010;33(11):1553–61.PubMedCentralPubMedGoogle Scholar
  118. 118.
    Roth T, Heith DH, Jochelson P, et al. Efficacy and safety of doxepin 6 mg in a model of transient insomnia. Sleep Med. 2010;11(9):843–7.PubMedCrossRefGoogle Scholar
  119. 119.
    Krystal AD, Lankford A, Durrence HH, et al. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep. 2011;34(10):1433–42.PubMedCentralPubMedGoogle Scholar
  120. 120.
    Lankford A, Rogowski R, Essink B, Ludington E, Heith DH, Roth T. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Med. 2012;13(2):133–8.PubMedCrossRefGoogle Scholar
  121. 121.
    Hajak G, Rodenbeck A, Voderholzer U, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry. 2001;62(6):453–63.PubMedCrossRefGoogle Scholar
  122. 122.
    Pieper AA, Treisman GJ. Drug treatment of depression in HIV-positive patients: safety considerations. Drug Saf. 2005;28(9):753–62.PubMedCrossRefGoogle Scholar
  123. 123.
    Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry. 2010;81(12):1372–3.PubMedCrossRefGoogle Scholar
  124. 124.
    Hill L, Lee KC. Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics. Ann Pharmacother. 2013;47(1):75–89.PubMedCrossRefGoogle Scholar
  125. 125.
    Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy. 1997;17(1):10–21.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2015

Authors and Affiliations

  1. 1.The University of Tennessee, College of NursingKnoxvilleUSA

Personalised recommendations